WHO ICTRP trial
Hit hard and early. The effect of high dose methylprednisolon on nailfold…
EUCTR2015-004613-24-BE · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2015-004613-24-BE |
|---|---|
| Public title | Hit hard and early. The effect of high dose methylprednisolon on nailfold capillary changes and biomarkers in early SSc: a 12-week randomized explorative double-blind placebo-controlled trial. |
| Scientific title | Hit hard and early. The effect of high dose methylprednisolon on nailfold capillary changes and biomarkers in early SSc: a 12-week randomized explorative double-blind placebo-controlled trial. - Hit hard and early |
| Primary sponsor | Radboudumc |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Belgium;Netherlands |
| Conditions | (very early) systemic sclerosis;Therapeutic area: Diseases [C] - Immune System Diseases [C20] |
| Interventions | Trade Name: Solu-Medrol Product Name: methylprednisolon Pharmaceutical Form: Powder and solvent for solution for injection INN or Proposed INN: METHYLPREDNISOLONE SODIUM SUCCINATE Other descriptive name: METHYLPREDNISOLONE SODIUM SUCCINATE… |
| Registration date | Apr 18, 2019 |
| Target size | 30 |
| Secondary IDs | 14102015.V1.0;NCT03059979;2015-004613-24-NL |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: